Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZG7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,040
Award facts
- Contract value 100% obligated
- $13,039.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections with a contract ceiling value of $13,039.92. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor contract running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal medical supply contracts with the DLA, supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This particular delivery order for Zepbound reflects the company's role in providing diabetes and obesity management medications to Defense Health Agency and other government healthcare customers. As a child contract under the broader SPE2DX IDC vehicle, this order demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements through competitive, firm fixed-price mechanisms.
Quick answers
Who was awarded contract SPE2DR26F0ZG7?
SPE2DR26F0ZG7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F0ZG7 worth?
The government has obligated $13,040 on SPE2DR26F0ZG7.
Is contract SPE2DR26F0ZG7 an order under another contract?
Yes. SPE2DR26F0ZG7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZG7 competed?
The extent of competition for SPE2DR26F0ZG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award